Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polynucleotides encoding humanized anti-NGF antibodies

Polynucleotides encoding humanized anti-NGF antibodies

US Patent 8877491 · Granted Nov 4, 2014

Estimated economic value: $112,858,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intrabodies targeting post-translational modifications of native proteins and me2021
Molecules that are able to inhibit the binding between NGF and the TrkA receptor2017
Method for the humanization of antibodies and humanized antibodies thereby obtai2012
Method for the humanization of antibodies and humanized antibodies thereby obtai2012
Method for the humanization of antibodies and humanized antibodies thereby obtai2012
Method for the treatment of pain with humanized anti-nerve growth factor antibod2012
Method for the treatment of pain with humanized anti-nerve growth factor antibod2012
Method for the treatment of pain with humanized anti-nerve growth factor antibod2012
Humanized anti-nerve growth factor antibodies2012
Humanized anti-nerve growth factor antibodies2012
Humanized anti-nerve growth factor antibodies2012
Method for the potentiation of opioid analgesics effects on pain2011